Skip to main content
Fig. 1 | Critical Care

Fig. 1

From: Serum IL-17 levels are higher in critically ill patients with AKI and associated with worse outcomes

Fig. 1

Serum IL-17A levels stratified by acute kidney injury status (Panel A), inpatient mortality (Panel B), and major adverse kidney events (Panel C). T1 = 24–48 h of AKI diagnosis or ICU admission (no AKI); T2 = 5–7 days after initial sample. N = number of patients at each represented category. *p < 0.05

Back to article page